CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that a federal jury in Boston awarded it $3.3 million in damages for patent infringement by Philips Electronics North America Corporation. ZOLL’s two patents were associated with high-impedance defibrillation electrodes that reduce burns, and monitoring for life-threatening heart rhythms.
The jury also determined that ZOLL should pay Philips and its parent company $8.9 million in damages for infringement of one patent concerning performing wake-up self-tests in an AED, plus $1.5 million for infringing two patents associated with monitoring patient impedance while delivering a biphasic waveform. Philips had been seeking total damages of $217 million, the vast majority for infringement of the two waveform patents.
“We are satisfied that the jury has been fair in awarding reasonable damages under the circumstances,” said Jonathan Rennert, Chief Executive Officer. “The patents in question are all expired and there is no impact on ZOLL’s day-to-day business. We look forward to continuing to focus on market opportunities where our defibrillator technology enjoys standard of care status.”
Both companies had previously been found liable for infringing each other’s defibrillator-related patents in a separate jury trial in 2013.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the material, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.